Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S.3794 SAFE Drugs Act H.R.6509 SAFE Drugs Act Drug Enforcement Administration's special registrations for telemedicine and limited state telemedicine registrations Matters related to compounding, telehealth, and healthcare
S.3794 SAFE Drugs Act H.R.6509 SAFE Drugs Act Drug Enforcement Administration's special registrations for telemedicine and limited state telemedicine registrations Matters related to compounding, telehealth, and healthcare
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2026 · third_quarter · Q3
S.3794 SAFE Drugs Act H.R.6509 SAFE Drugs Act Drug Enforcement Administration's special registrations for telemedicine and limited state telemedicine registrations Matters related to compounding, telehealth, and healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2026 · second_quarter · Q2
Source: Senate LDA
Healthy Technology Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Healthy Technology Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Healthy Technology Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Drug Shortage Compounding Patient Access Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Drug Shortage Compounding Patient Access Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Drug Shortage Compounding Patient Access Act of 2025
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
A bill to amend the Internal Revenue Code of 1986 to impose limitations on high-income taxpayers with large retirement account balances.
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
A bill to amend the Internal Revenue Code of 1986 to impose limitations on high-income taxpayers with large retirement account balances.
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
A bill to amend the Internal Revenue Code of 1986 to impose limitations on high-income taxpayers with large retirement account balances.
Client: HIMS & HERS HEALTH, INC. · Firm: HIMS & HERS HEALTH, INC.
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Matters related to compounding, telehealth, and healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2026 · first_quarter · Q1
Matters related to compounding, telehealth, and healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · third_quarter · 3A
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · second_quarter · 2A
Telehealth Compounded medicines Quality and safety manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · first_quarter · 1A
Drug shortage list FDA transparency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · fourth_quarter · Q4
Matters related to compounding, telehealth, and healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · third_quarter · 3A
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · third_quarter · Q3
Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · second_quarter · Q2
Telehealth Compounded medicines Quality and safety manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · first_quarter · 1A
Drug shortage list FDA transparency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via HIMS & HERS HEALTH, INC.
2025 · first_quarter · RR
All matters affecting telehealth services
All matters affecting telehealth services
All matters affecting telehealth services
All matters affecting telehealth services
All matters affecting telehealth services